2023-2029 Global Eosinophilic Disease Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Eosinophilic Disease Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Eosinophilic Disease Market Restraints
Table 3. Eosinophilic Disease Market Trends
Table 4. Eosinophilic Disease Industry Policy
Table 5. Global Eosinophilic Disease Revenue by Company, 2018-2023, US$ million
Table 6. Global Eosinophilic Disease Revenue Market Share by Company, 2018-2023
Table 7. Global Eosinophilic Disease Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Eosinophilic Disease Sales Volume Market Share by Company, 2018-2023
Table 9. Global Eosinophilic Disease Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Eosinophilic Disease Mergers & Acquisitions, Expansion Plans
Table 12. Global Eosinophilic Disease Manufacturers Product Type
Table 13. China Eosinophilic Disease Revenue by Company, 2018-2023, US$ million
Table 14. China Eosinophilic Disease Revenue Market Share by Company, 2018-2023
Table 15. China Eosinophilic Disease Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Eosinophilic Disease Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Eosinophilic Disease Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Eosinophilic Disease Import & Export Trends
Table 19. Main Sources of China Eosinophilic Disease Import
Table 20. Export Destination of China Eosinophilic Disease
Table 21. Global Headquarters and Manufacturing Base of Eosinophilic Disease Manufacturers
Table 22. Global Major Manufacturers, Eosinophilic Disease Capacity Expansion and Future Plans
Table 23. Global Eosinophilic Disease Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Eosinophilic Disease Production by Region, 2018-2023, (K Units)
Table 25. Global Eosinophilic Disease Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Eosinophilic Disease Upstream (Raw Materials)
Table 27. Global Eosinophilic Disease Typical Customers
Table 28. Eosinophilic Disease Typical Distributors
Table 29. By Type, Global Eosinophilic Disease Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Eosinophilic Disease Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Eosinophilic Disease Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Eosinophilic Disease Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Eosinophilic Disease Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Eosinophilic Disease Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Eosinophilic Disease Revenue Market Share, 2018-2029
Table 37. By Country, Global Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Eosinophilic Disease Sales Volume Market Share, 2018-2029
Table 39. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position
Table 40. Takeda Pharmaceutical Company Limited Eosinophilic Disease Models, Specifications and Application
Table 41. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Takeda Pharmaceutical Company Limited Company Profile and Main Business
Table 43. Takeda Pharmaceutical Company Limited Recent Developments
Table 44. Ellodi Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 45. Ellodi Pharmaceuticals Eosinophilic Disease Models, Specifications and Application
Table 46. Ellodi Pharmaceuticals Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Ellodi Pharmaceuticals Company Profile and Main Business
Table 48. Ellodi Pharmaceuticals Recent Developments
Table 49. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 50. Bristol-Myers Squibb Company Eosinophilic Disease Models, Specifications and Application
Table 51. Bristol-Myers Squibb Company Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bristol-Myers Squibb Company Company Profile and Main Business
Table 53. Bristol-Myers Squibb Company Recent Developments
Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 55. AstraZeneca Eosinophilic Disease Models, Specifications and Application
Table 56. AstraZeneca Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AstraZeneca Company Profile and Main Business
Table 58. AstraZeneca Recent Developments
Table 59. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 60. GSK plc Eosinophilic Disease Models, Specifications and Application
Table 61. GSK plc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GSK plc Company Profile and Main Business
Table 63. GSK plc Recent Developments
Table 64. Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Regeneron Pharmaceuticals Inc Eosinophilic Disease Models, Specifications and Application
Table 66. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Regeneron Pharmaceuticals Inc Company Profile and Main Business
Table 68. Regeneron Pharmaceuticals Inc Recent Developments
Table 69. Allakos Inc Company Information, Head Office, Market Area and Industry Position
Table 70. Allakos Inc Eosinophilic Disease Models, Specifications and Application
Table 71. Allakos Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Allakos Inc Company Profile and Main Business
Table 73. Allakos Inc Recent Developments
Table 74. Arena Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. Arena Pharmaceuticals Ltd Eosinophilic Disease Models, Specifications and Application
Table 76. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Arena Pharmaceuticals Ltd Company Profile and Main Business
Table 78. Arena Pharmaceuticals Ltd Recent Developments
Table 79. Revolo Biotherapeutics Company Information, Head Office, Market Area and Industry Position
Table 80. Revolo Biotherapeutics Eosinophilic Disease Models, Specifications and Application
Table 81. Revolo Biotherapeutics Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Revolo Biotherapeutics Company Profile and Main Business
Table 83. Revolo Biotherapeutics Recent Developments
Table 84. DBV Technologies Company Information, Head Office, Market Area and Industry Position
Table 85. DBV Technologies Eosinophilic Disease Models, Specifications and Application
Table 86. DBV Technologies Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. DBV Technologies Company Profile and Main Business
Table 88. DBV Technologies Recent Developments
Table 89. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 90. Cipla Inc Eosinophilic Disease Models, Specifications and Application
Table 91. Cipla Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Cipla Inc Company Profile and Main Business
Table 93. Cipla Inc Recent Developments
Table 94. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 95. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Models, Specifications and Application
Table 96. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 98. Sun Pharmaceutical Industries Ltd Recent Developments
Table 99. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 100. Sanofi Eosinophilic Disease Models, Specifications and Application
Table 101. Sanofi Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Sanofi Company Profile and Main Business
Table 103. Sanofi Recent Developments
List of Figure
Figure 1. Eosinophilic Disease Picture
Figure 2. By Revenue, Global Eosinophilic Disease Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Eosinophilic Disease Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Eosinophilic Disease Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Eosinophilic Disease Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Eosinophilic Disease Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Eosinophilic Disease Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Eosinophilic Disease Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Eosinophilic Disease Share of Global Market, 2018-2029
Figure 10. Global Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Eosinophilic Disease Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Eosinophilic Disease Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Eosinophilic Disease Domestic VS Export, 2022
Figure 16. Global Eosinophilic Disease Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Eosinophilic Disease Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Eosinophilic Disease Production Market Share & Forecast by Region, 2018-2029
Figure 19. Eosinophilic Disease Industry Chain
Figure 20. Eosinophilic Disease Procurement Model
Figure 21. Eosinophilic Disease Sales Model
Figure 22. Eosinophilic Disease Sales Channels, Direct Sales and Distribution
Figure 23. Corticosteroids
Figure 24. Monoclonal Antibodies
Figure 25. Anti-cytokine Drug
Figure 26. Cytotoxic Drug
Figure 27. By Type, Global Eosinophilic Disease Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Eosinophilic Disease Revenue Market Share, 2018-2029
Figure 29. By Type, Global Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Eosinophilic Disease Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Eosinophilic Disease Price, 2018-2029, (US$/Unit)
Figure 32. Eosinophilic Esophagitis
Figure 33. Eosinophilic Granulomatosis with Polyangiitis
Figure 34. Hyper-eosinophilic Syndrome
Figure 35. Nasal Polyposis
Figure 36. Other
Figure 37. By Application, Global Eosinophilic Disease Revenue, 2018-2029, US$ Million
Figure 38. By Application, Global Eosinophilic Disease Revenue Market Share, 2018-2029
Figure 39. By Application, Global Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 40. By Application, Global Eosinophilic Disease Sales Volume Market Share, 2018-2029
Figure 41. By Application, Global Eosinophilic Disease Price, 2018-2029, (US$/Unit)
Figure 42. By Region, Global Eosinophilic Disease Revenue Market Share, 2018-2029
Figure 43. By Region, Global Eosinophilic Disease Sales Volume Market Share, 2018-2029
Figure 44. North America Eosinophilic Disease Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, North America Eosinophilic Disease Revenue Market Share, 2022
Figure 46. Europe Eosinophilic Disease Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, Europe Eosinophilic Disease Revenue Market Share, 2022
Figure 48. Asia Pacific Eosinophilic Disease Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country/Region, Asia Pacific Eosinophilic Disease Revenue Market Share, 2022
Figure 50. South America Eosinophilic Disease Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country, South America Eosinophilic Disease Revenue Market Share, 2022
Figure 52. Middle East & Africa Eosinophilic Disease Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. U.S. Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, U.S. Eosinophilic Disease Market Share, 2022
Figure 55. By Type, U.S. Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, U.S. Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, Europe Eosinophilic Disease Market Share, 2022
Figure 59. By Type, Europe Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, Europe Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 61. China Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, China Eosinophilic Disease Market Share, 2022
Figure 63. By Type, China Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, China Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 65. Japan Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, Japan Eosinophilic Disease Market Share, 2022
Figure 67. By Type, Japan Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, Japan Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 69. South Korea Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, South Korea Eosinophilic Disease Market Share, 2022
Figure 71. By Type, South Korea Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, South Korea Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 73. Southeast Asia Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, Southeast Asia Eosinophilic Disease Market Share, 2022
Figure 75. By Type, Southeast Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, Southeast Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 77. India Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, India Eosinophilic Disease Market Share, 2022
Figure 79. By Type, India Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, India Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 81. Middle East & Asia Eosinophilic Disease Sales Volume, 2018-2029, (K Units)
Figure 82. By Company, Middle East & Asia Eosinophilic Disease Market Share, 2022
Figure 83. By Type, Middle East & Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 84. By Application, Middle East & Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets